1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia

Opción 1: Descargar recurso

Detalles del recurso


Aggressive B-cell lymphoma (BCL) comprises a heterogeneous group of malignancies, including diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma, and mantle cell lymphoma (MCL). DLBCL, with its 3 subtypes, is the most common type of lymphoma. Advances in chemoimmunotherapy have substantially improved disease control. However, depending on the subtype, patients with DLBCL still exhibit substantially different survival rates. In MCL, a mature B-cell lymphoma, the addition of rituximab to conventional chemotherapy regimens has increased response rates, but not survival. Burkitt lymphoma, the most aggressive BCL, is characterized by a high proliferative index and requires more intensive chemotherapy regimens than DLBCL. Hence, there is a need for more effective therapies for all three diseases. Increased understanding of the molecular features of aggressive BCL has led to the development of a range of novel therapies, many of which target the tumor in a tailored manner and are summarized in this paper.

Pertenece a

PubMed Central (PMC3 - NLM DTD)  


Foon, Kenneth A. -  Takeshita, Kenichi -  Zinzani, Pier L. - 

Id.: 55223208

Idioma: inglés  - 

Versión: 1.0

Estado: Final

Palabras claveReview Article - 

Tipo de recurso: Text  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 27-abr-2012



Otros recursos del mismo autor(es)

  1. A Phase 2 Study of Belinostat (PXD101) in Patients with Relapsed or Refractory Acute Myloid Leukemia or Patients Over 60 with Newly-Diagnosed Acute Myloid Leukemia: A California Cancer Consortium Study We performed a phase II study of belinostat in patients with acute myloid leukemia (AML). In this op...
  2. The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells Chronic lymphocytic leukemia (CLL) is a common malignancy characterized by the accumulation of B lym...
  3. A phase I trial of recombinant gamma interferon in patients with cancer A total of 11 patients were treated on an escalating, single dose trial of recombinant gamma interfe...
  4. Biological therapy of cancer Interferons and monoclonal antibodies are among the most promising biological approaches to cancer t...
  5. Immunologic classification of lymphoma and lymphoid leukemia Important insights into lymphocyte differentiation and the cellular origins of lymphoma and lymphoid...

Otros recursos de la misma colección

  1. Plasticizer Effects in the PVC Membrane of the Dibasic Phosphate Selective Electrode The PVC membrane of an ion-selective electrode (ISE) sensitive to dibasic phosphate ions (HPO4-ISE) ...
  2. Medicinal Chemistry of Cannabinoids The endocannabinoid system comprises the two well characterized Gi/o-protein coupled receptors (cann...
  3. Bacterial diversity along a 2600 km river continuum The bacterioplankton diversity in large rivers has thus far been under-sampled despite the importanc...
  4. The Popeye Domain Containing Genes and their Function in Striated Muscle The Popeye domain containing (POPDC) genes encode a novel class of cAMP effector proteins, which are...
  5. Language lateralization of hearing native signers: A functional transcranial Doppler sonography (fTCD) study of speech and sign production Neuroimaging studies suggest greater involvement of the left parietal lobe in sign language compared...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.